Capabilities

Support across themedicine lifecycle.

From pre-commercialisation and market readiness to specialist launch, supply and complex-therapy delivery.

Pre-commercialisation

Get launch-ready.

Market opportunity

Patient need, treatment pathways and local feasibility.

Regulatory strategy

Dossier readiness, pathways and submission planning.

Market access & pricing

Reimbursement evidence, HTA and funding pathways.

Medical engagement

Scientific exchange and clinical advisory input.

Launch architecture

Distribution, pharmacy pathways and launch milestones.

Commercialisation

Precision-led execution.

Specialist account management

Experienced teams who know the clinical area.

Hospital & payer access

Formularies, tenders and procurement.

Supply & continuity

Forecasting, cold chain, GDP logistics and quality.

Medical affairs

Medical education, safety reporting and lifecycle planning.

Performance & governance

Clear plans, budgets and reporting against your goals.

Scientist handling a cryogenic vial in a cell therapy laboratory

Advanced therapies & supply solutions

Networks for complex medicines.

Specialist therapies

Biologics, cell and gene therapies and other advanced treatments.

Delivery design

Treatment-centre readiness, validated logistics and chain of identity.

Regional manufacturing

CDMO, packaging and tech-transfer options where warranted.

ANZ & Asia-Pacific

Developing a medicine for ANZ or APAC?

Talk to us about a market-entry strategy built around your asset.

Partner with Vitalis